Navigation Links
CVS Caremark Research Tailors Consumer Communications to Encourage Better Medication Behavior
Date:5/24/2011

WOONSOCKET, R.I., May 24, 2011 /PRNewswire/ -- CVS Caremark today outlined the results of an innovative, personalized consumer communications program designed to encourage patients to take their medications as doctors direct. Early results of the program show increases in consumers signing up for automatic prescription refills and more readily substituting generic medications for brand medicines to lower costs.

(Logo: http://photos.prnewswire.com/prnh/20090226/NE75914LOGO)

The program to continually improve consumer communications is part of a collaboration CVS Caremark has initiated with behavioral economists from the Wharton School of Business at the University of Pennsylvania, Tuck Business School at Dartmouth College and Carnegie Mellon University.  Kevin Volpp from Wharton, Punam Keller from Tuck and George Loewenstein from Carnegie Mellon are members of CVS Caremark's Behavior Change Research Partnership (BCRP), formed by the company to apply  behavioral economics to improve how pharmacy care is provided to customers.

The findings from the research were outlined today at Silverlink's RESULTS 2011: The Consumer Health Engagement Conference by Bari Harlam, senior vice president of Member Engagement for CVS Caremark. The conference, held in Boston today and tomorrow, is focusing on innovative ways health care companies can engage consumers to take a more active role in their health care decisions.

In her remarks, Harlam said that CVS Caremark is measuring the impact of different communications using behavioral science principles of making messages timely, relevant, easy to understand and easy to implement. In addition, such information can be tailored to outline individual medication and cost options to give consumers a chance to consider their own potential cost savings.

"By giving patients who are signing up for prescriptions online an active choice concerning their care, we have seen a significant improvement in the number of people signing up for our automatic prescription refill program," Harlam said. "By providing personalized prescription guides that outline options in easy to understand language – whether the communications be on the telephone, face-to-face with pharmacists or by letter – we are seeing an increase in the numbers of patients willing to consider generics."

Harlam said CVS Caremark is investing in behavioral change research and continuous efforts to enhance communication as part of its effort to improve customer service to keep patients adherent to their medicines. By helping customers take their medications as doctors direct, they can avoid unnecessary health care costs and hospitalizations. "These programs are exciting because they offer the opportunity to improve the quality of pharmacy care while helping to reduce overall medical costs," Harlam said.  

CVS Caremark has also invested in research targeting medication adherence through a three-year collaboration with Harvard and Brigham and Women's Hospital.

About CVS Caremark

CVS Caremark is the largest pharmacy health care provider in the United States with integrated offerings across the entire spectrum of pharmacy care. We are uniquely positioned to engage plan members in behaviors that improve their health and to lower overall health care costs for health plans, plan sponsors and their members. CVS Caremark is a market leader in mail order pharmacy, retail pharmacy, specialty pharmacy, and retail clinics, and is a leading provider of Medicare Part D Prescription Drug Plans. As one of the country's largest pharmacy benefits managers (PBMs), we provide access to a network of approximately 65,000 pharmacies, including more than 7,200 CVS/pharmacy® stores that provide unparalleled service and capabilities. Our clinical offerings include our signature Pharmacy Advisor™ program as well as innovative generic step therapy and genetic benefit management programs that promote more cost effective and healthier behaviors and improve health care outcomes. General information about CVS Caremark is available through the Company's website at http://info.cvscaremark.com/.

Media Contact:
Jon Sandberg
CVS Caremark
(401) 770 4914
jlsandberg@cvs.com


'/>"/>
SOURCE CVS Caremark
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. CVS Caremark to Present at the Sanford C. Bernstein Strategic Decisions Conference
2. CVS Caremark to Participate in the Citi Investment Research 2011 Global Consumer Conference
3. CVS Caremark to Pilot Electronic Prior Authorization to Help Speed Patient Access to Prescription Medication
4. CVS Caremark Named as Finalist for 2011 URAC Award for Best Practices in Health Care Consumer Empowerment and Protection
5. CVS Caremark Uniquely Integrated Business Well-Positioned to Deliver Shareholder Value
6. CVS Caremark Reports First Quarter Results
7. CVS Caremark to Complete Acquisition of Universal Americans Medicare Part D Business
8. NCPA Responds to Consumer Groups Request for CVS Caremark Divestiture
9. CVS Caremark to Offer Medical Benefit Drug Management Services to Clients
10. CVS Caremark Insights 2011 Report Highlights Lowest Drug Trend in Six Years and Increased Utilization of Generics
11. CVS Caremark Named One of Americas Most Reputable Companies by Reputation Institute
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... -- IRIDEX Corporation (NASDAQ: IRIX ) today announced ... stock, $0.01 par value (the "Offering" with such shares being ... terms of the Offering will depend on market and other ... no assurance as to whether or when the Offering may ... proceeds it will receive from this offering for working capital ...
(Date:12/8/2016)... 8, 2016 Global Interventional Radiology Market: ... global interventional radiology market analyzes the current and ... an elaborate executive summary, including a market snapshot ... sub-segments. The research is a combination of ... bulk of our research efforts along with information ...
(Date:12/8/2016)... -- Eli Lilly and Company (NYSE: LLY ) ... trial at the 9 th Clinical Trials on ... not meet the primary endpoint in the EXPEDITION3 clinical ... mild dementia due to Alzheimer,s disease (AD), and Lilly ... treatment of mild dementia due to AD. ...
Breaking Medicine Technology:
(Date:12/8/2016)... ... December 08, 2016 , ... The Florida Hospital ... and Hyperbaric Medical Society (UHMS), the leading authority in hyperbaric medicine. This accreditation ... a few hospitals and facilities have earned this distinction. This is the second ...
(Date:12/8/2016)... ... 2016 , ... Mirixa Corporation , a leading healthcare ... patient care services, has announced the promotions of Karen Litsinger to senior vice ... sales. , Litsinger joined Mirixa in 2008 after serving as a partner ...
(Date:12/8/2016)... (PRWEB) , ... December 08, 2016 , ... ... modes of access for customers and employees that are both engaging and easy ... with Service Smart Technology, the software company revealed today its plans to roll ...
(Date:12/8/2016)... ... , ... California Senate Bill (SB) 863, signed into law in 2012, may ... 2014, according to CompScope™ Medical Benchmarks for California, 17th Edition , a study ... medical payments per claim in California decreased 4 percent in 2013 and then 3 ...
(Date:12/8/2016)... ... December 08, 2016 , ... ... planning services from offices headquartered in Hamilton County, is embarking on a charity ... LuvFurMutts specializes in finding new homes for orphaned or neglected senior dogs in ...
Breaking Medicine News(10 mins):